Literature DB >> 17071839

Inhaled corticosteroids and long term outcome in adults with asthma.

P J F M Merkus, J C de Jongste.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17071839      PMCID： PMC2121169          DOI： 10.1136/thx.2006.062810

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  6 in total

1.  Long-term effects of budesonide or nedocromil in children with asthma.

Authors:  Stanley Szefler; Scott Weiss; James Tonascia; N Franklin Adkinson; Bruce Bender; Reuben Cherniack; Michele Donithan; H William Kelly; Joseph Reisman; Gail G Shapiro; Alice L Sternberg; Robert Strunk; Virginia Taggart; Mark Van Natta; Robert Wise; Margaret Wu; Robert Zeiger
Journal:  N Engl J Med       Date:  2000-10-12       Impact factor: 91.245

2.  Inhaled corticosteroids and decline of lung function in community residents with asthma.

Authors:  P Lange; H Scharling; C S Ulrik; J Vestbo
Journal:  Thorax       Date:  2006-02       Impact factor: 9.139

3.  Inhaled corticosteroids moderate lung function decline in adults with asthma.

Authors:  P Ernst
Journal:  Thorax       Date:  2006-02       Impact factor: 9.139

4.  Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex.

Authors:  A Dijkstra; J M Vonk; H Jongepier; G H Koppelman; J P Schouten; N H T ten Hacken; W Timens; D S Postma
Journal:  Thorax       Date:  2005-11-24       Impact factor: 9.139

5.  Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group.

Authors:  J K Sont; L N Willems; E H Bel; J H van Krieken; J P Vandenbroucke; P J Sterk
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

6.  Inhaled corticosteroids and growth of airway function in asthmatic children.

Authors:  P J F M Merkus; W van Pelt; J C van Houwelingen; L E M van Essen-Zandvliet; E J Duiverman; K F Kerrebijn; P H Quanjer
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.